GHK-Cu (glycine-histidine-lysine-copper) is a tripeptide that occurs naturally in human plasma, with concentrations declining significantly after age 60
However, as of 2024 they have been included in the World Anti-Doping Agencys monitoring program, which tracks usage patterns and examines whether the drugs provide an unfair advantage or pose health risks and they could be banned in the future.
In studies, most nausea, diarrhea, and vomiting occurred when people increased their dose, but the effects generally decreased over time
Oxidation and enhanced energy expenditure appeared to be vital in the proposed action of the peptide
"So if you were looking for a therapeutic that could potentially improve aging or have some sort of impact, that would be the starting point." Researchers compared participants who received weekly semaglutide injections with others who received a placebo
Can creatine supplementation support cognition